CHUM Research Centre
Interdisciplinary urologic oncology group, CHUM
Prostate cancer research, Montreal Cancer Institute / CRCHUM
Department of surgery, Université de Montréal
Raymond Garneau Chair in Prostate Cancer, Université de Montréal
514 890-8000, ext. 27466
The patient who needs immediate assistance should not communicate directly with the researcher. Instead, they should call the doctor’s office or take other appropriate measures, such as going to the nearest emergency service.
CHUM's Urologic Oncology Clinic and the Prostate Cancer Molecular Oncology Laboratory in the Montreal Cancer Institute.President, Canadian Urologic Oncology Group (CUOG) and National Cancer Institute of Canada G-U (NCIC G-U)
Canadian Prostate Health Council and Global G-U
Alliance-Procure biobank, which brings together the four universities in Quebec
Board of Directors of: The Montreal Cancer Institute, National Cancer Institute of Canada, Procure Alliance
Oncological urology, prostate cancer, tissue bank, prognostic markers in prostate cancer, hormone-refractory cancer.
Research on prognostic molecular markers in prostate cancer and hormone-refractory prostate cancer.
Founder of the Oncology Urology Clinic at the University Hospital of Montreal (CHUM) and the Molecular Oncology Laboratory in Prostate Cancer at the Montreal Cancer Institute.